Aesthetic Medical International Holdings Group Ltd.

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Aesthetic Medical International's third quarter 2020 Unaudited Financial Results conference call. During today's presentation, all parties will be in a listen-only mode. This conference has been recorded today, Monday, November 30, 2020. If you require operator assistance, please press star then zero. Joining us today from Aesthetic Medical International are the company's chairman and CEO, Dr. Pengwu Zhou, and the company's IRD, Mr. Zeng Yiquan, and the company's financial officer, Mr. Guanhua Wu. Before we get started, I would like to remind you that some of the information discussed will include forward-looking statements regarding future events and our future financial performance. These include statements about our future expectations, financial projections, and our plans and prospects. Actual results may differ materially from those set forth in such statements. For discussion of the risks and uncertainties, you should review the company's filings with the SEC, which includes today's press release. You should not rely on our forward-looking statements as predictions of future events. All forward-looking statements that we make on this call are based on assumptions and beliefs as of today, and we undertake no obligation to update them except as required by applicable law. Our discussion today will include non-IFRS financial measures, including EBITDA, adjusted profit, and adjusted EBITDA. you should not consider EBITDA, adjusted EBITDA, and adjusted profit as a substitute or are superior to net income prepared in accordance with IFRS. Furthermore, because non-IFRS measures are not determined in accordance with IFRS, they are susceptible to varying calculations and may not be comparable to other similarly titled measures presented by other companies. You are encouraged to review the company's financial information in its entirety and not rely on a single financial measure. At this time, I would like to turn the call over to Mr. Peng Wuzhong, Chairman and CEO of Aesthetic Medical International. His opening remarks be delivered in English by IRD Mr. Sung Yik Wong.

Mr. Zhou, please go ahead. Let me summarize for you the response measures of the company for the COVID-19 pandemic in the third quarter of 2020 and the performance of the company in the third quarter of 2020. Then, with our investor relations director, Mr. Jiang, to interpret and explain in more detail our financial statements, the operating status of the company, and the relevant situation of the company's future development,

Thank you, operator, and everyone for joining Aesthetic Medical International's third quarter 2020 and audit earning conference call today. I will begin my remarks by providing an overview of the company's response to the COVID-19 outbreak during the third quarter 2020, followed by a summary. of the company's third quarter 2020 performance. Then Dr. Jenny Guang, our IRD, will review our financial results and operations performance in more detail. And she will elaborate a few other items related to our outlooks and the approaches we are taking to implement our initiatives in this fiscal year.